T2 Biosystems, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
TTOO on Nasdaq
Location
101 Hartwell Avenue, Lexington, Massachusetts

Insiders trading volume in the past year

T2 Biosystems, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
CR Group L.P. 10%+ Owner $741K -$12.9M -94.5% May 9, 2024
Goldman Sachs & Co. Llc 10%+ Owner $662K Mar 24, 2020
Adrian M. Jones Director $662K Mar 24, 2020
Aparna Ahuja Chief Medical Officer $94.5K Feb 20, 2022
John McDonough Director $94.2K Jul 1, 2021
Alec Barclay Chief Operations Officer $28.7K Apr 8, 2022
Robin Toft Director $1.91K Jan 1, 2024
David B. Elsbree Director $1.26K Sep 15, 2023
Ninfa Saunders Director $1.15K Sep 15, 2023
Thierry Bernard Director $1.15K Sep 15, 2023
Seymour Liebman Director $1.1K Sep 15, 2023
John W. Cumming Director $828 Sep 15, 2023
John J. Sperzel III Officer, Director $63.00 Feb 24, 2024
John M. Sprague Chief Financial Officer $22.00 Feb 24, 2024
Michael Terrence Gibbs General Counsel $21.00 Feb 24, 2024
Brett A. Giffin Chief Commercial Officer $14.00 Feb 20, 2024
Laura Lee Adams Director $7.00 Oct 18, 2023

Recent Insider Transactions by Companies or Individuals for T2 Biosystems, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.